Parmar Kush's Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Jul 11, 2025
- Accession no.
- 0001415889-25-019680
- Filed
- Jul 11, 2025
- Trade date
- Jul 9, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $202.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parmar KushCIK 0001664281 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | Common Stock | SSaleDisposed | −20,065 | $7.50 | −$150,487.5 | 3,163,066 | Indirect | |
| Jul 9, 2025 | Common Stock | SSaleDisposed | −6,935 | $7.50 | −$52,012.5 | 1,093,313 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.